SCHEMBL28048449

SCHEMBL28048449

CC1(C)CCC(C(=O)C2CCC(C)(C)CC2)CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APLNR P35414 1/20 0.40
EPHX2 P34913 1/20 0.37
CHRNB2 P17787 2/20 0.34
CHRNB4 P30926 2/20 0.34
CHRNA3 P32297 2/20 0.34
CHRNA4 P43681 2/20 0.34
CHRNA7 P36544 1/20 0.34
LMNA P02545 3/20 0.33
BLM P54132 2/20 0.33
FFAR3 O14843 1/20 0.33
GRM2 Q14416 2/20 0.32
GRM3 Q14832 2/20 0.32
GRM4 Q14833 2/20 0.32
CYP2C19 P33261 2/20 0.32
MTOR P42345 2/20 0.32
CYP1A2 P05177 1/20 0.32
ALOX15 P16050 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
GRM8 O00222 1/20 0.32
GRM6 O15303 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1840371 0.81 EPHX2 (0.40) APLNREPHX2LMNABLMFFAR3
SCHEMBL4443561 0.81 APLNR (0.56) APLNREPHX2LMNABLMFFAR3
SCHEMBL6628367 0.79 APLNR (0.37) APLNREPHX2LMNABLMFFAR3
SCHEMBL2232346 0.79 SMN1; SMN2 (0.43) APLNREPHX2LMNABLMGRM2
SCHEMBL20854992 0.77 EPHX2 (0.38) APLNREPHX2LMNABLMTSHR
SCHEMBL19913354 0.75 APLNR (0.34) APLNREPHX2LMNABLM
SCHEMBL4915472 0.75 TP53 (0.46) EPHX2CHRNB2CHRNB4CHRNA3CHRNA4
SCHEMBL3631699 0.75 APLNR (0.34) APLNREPHX2LMNABLMTSHR
SCHEMBL17574160 0.74 APLNR (0.33) APLNREPHX2LMNABLM
SCHEMBL23263231 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104053661-B The thienopyrimidines inhibitor of atypical protein kinase C 癌症研究技术有限公司 2018-06-19 CN disclosed
CN-104024258-B Pyrrolopyrazine kinase inhibitors 霍夫曼-拉罗奇有限公司 2017-02-15 CN disclosed
CN-103443099-B Regulate composition and the method for FXR NOVARTIS AG (CH) 2016-03-23 CN disclosed
CN-101686680-B Bicyclic heteroaryl compounds as P2X7 modulators and uses thereof Ivotec America Inc. (US) 2015-12-09 CN disclosed